Search

everythinglearnresearchcommunity

for

Search:↓

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Genetic factors in PCOS are complex, with potential influences from the MC4R gene.

Managing PCOD involves lifestyle changes like exercise, healthy eating, and avoiding smoking and alcohol.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Drinking a lot of sugary drinks may increase hair loss risk in young women.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

COVID-19 infection is linked to temporary hair loss in Egyptian women.

Quality pharmaceutical care is crucial for safe and effective use of vitamin-mineral supplements during pregnancy and breastfeeding.

A balanced diet rich in fruits, vegetables, and healthy fats is crucial for maintaining healthy hair and preventing hair loss.

FOXA1 and CCL2 genes are more active in women with PCOS, varying by phenotype.

Brownish halos around axillary hair can help diagnose frontal fibrosing alopecia.

Trichoscopy effectively helps diagnose different types of hair loss in women.

The document concludes that hair loss in women is treated with medications, therapies, and surgery in Western medicine, and with acupuncture and herbs in Chinese medicine, but hereditary hair loss is hard to reverse.

Viviscal may modestly improve hair loss in women without adverse effects.

Shift work disrupts the body's natural clock, leading to health problems.

Soy protein with isoflavones reduces wrinkles and improves skin hydration in postmenopausal women.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

DEEPLY ROOTED® supplement seems to effectively improve hair growth and quality in women with no side effects.

The supplement improved hair growth and reduced hair loss in women.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

Smoking may contribute to hair loss in men.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

The dual-serum cosmetic system effectively improves hair loss in women.